36.00
price down icon0.63%   -0.23
after-market アフターアワーズ: 36.48 0.48 +1.33%
loading
前日終値:
$36.23
開ける:
$36.53
24時間の取引高:
493.42K
Relative Volume:
0.48
時価総額:
$2.25B
収益:
-
当期純損益:
$-229.97M
株価収益率:
-8.3268
EPS:
-4.3234
ネットキャッシュフロー:
$-136.51M
1週間 パフォーマンス:
+4.59%
1か月 パフォーマンス:
-19.71%
6か月 パフォーマンス:
+60.43%
1年 パフォーマンス:
+946.51%
1日の値動き範囲:
Value
$35.77
$36.91
1週間の範囲:
Value
$34.49
$37.97
52週間の値動き範囲:
Value
$3.26
$47.84

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
名前
Kodiak Sciences Inc
Name
セクター
Healthcare (1111)
Name
電話
650-281-0850
Name
住所
1250 PAGE MILL RD, PALO ALTO, CA
Name
職員
124
Name
Twitter
@kodiaksciences
Name
次回の収益日
2026-05-13
Name
最新のSEC提出書
Name
KOD's Discussions on Twitter

Compare KOD vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
KOD icon
KOD
Kodiak Sciences Inc
36.00 2.27B 0 -229.97M -136.51M -4.3234
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-11 アップグレード H.C. Wainwright Neutral → Buy
2025-10-24 アップグレード JP Morgan Neutral → Overweight
2025-09-25 アップグレード Barclays Underweight → Equal Weight
2025-09-22 開始されました Jefferies Buy
2025-08-14 アップグレード JP Morgan Underweight → Neutral
2024-12-09 アップグレード Jefferies Hold → Buy
2024-09-05 開始されました H.C. Wainwright Neutral
2023-12-11 再開されました Goldman Sell
2023-11-17 アップグレード CapitalOne Equal Weight → Overweight
2023-07-27 ダウングレード UBS Buy → Neutral
2023-07-25 ダウングレード Chardan Capital Markets Buy → Neutral
2023-07-25 ダウングレード JP Morgan Neutral → Underweight
2023-07-24 ダウングレード CapitalOne Overweight → Equal Weight
2023-07-24 ダウングレード Jefferies Buy → Hold
2022-11-15 開始されました CapitalOne Overweight
2022-08-02 ダウングレード Citigroup Neutral → Sell
2022-02-24 ダウングレード JP Morgan Overweight → Neutral
2022-02-11 開始されました Goldman Buy
2022-02-02 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード ROTH Capital Neutral → Buy
2021-03-12 開始されました Evercore ISI Outperform
2021-03-01 ダウングレード Barclays Equal Weight → Underweight
2021-02-17 ダウングレード ROTH Capital Buy → Neutral
2021-01-25 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-12-17 開始されました Berenberg Buy
2020-12-16 開始されました UBS Buy
2020-12-11 開始されました Citigroup Neutral
2020-11-30 ダウングレード JP Morgan Overweight → Neutral
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-13 ダウングレード Goldman Buy → Neutral
2020-03-31 開始されました BMO Capital Markets Outperform
2020-03-03 開始されました Goldman Buy
2020-02-18 ダウングレード Barclays Overweight → Equal Weight
2020-02-06 開始されました SunTrust Buy
2020-01-08 開始されました ROTH Capital Buy
2020-01-03 開始されました Jefferies Buy
2019-12-24 開始されました JP Morgan Overweight
2019-10-15 繰り返されました Chardan Capital Markets Buy
2019-02-20 開始されました Chardan Capital Markets Buy
2018-10-29 開始されました Barclays Overweight
2018-10-29 開始されました BofA/Merrill Buy
2018-10-29 開始されました Morgan Stanley Overweight
すべてを表示

Kodiak Sciences Inc (KOD) 最新ニュース

pulisher
May 24, 2026

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally - AOL.com

May 24, 2026
pulisher
May 20, 2026

KOD Technical Analysis | Trend, Signals & Chart Patterns | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill

May 20, 2026
pulisher
May 19, 2026

Kodiak Sciences Inc stock (US50012K1051): earnings loss widens as biotech pushes retina pipeline - AD HOC NEWS

May 19, 2026
pulisher
May 17, 2026

Kodiak Sciences Inc stock (US50012K1051): what’s behind the latest volatility after eye disease se - AD HOC NEWS

May 17, 2026
pulisher
May 17, 2026

Boxer Capital Management Boosts Kodiak Sciences Holdings in Q1 2026News and Statistics - IndexBox

May 17, 2026
pulisher
May 16, 2026

Kodiak Sciences Inc stock (US50012K1051): Investors eye eye-disease pipeline after latest company up - AD HOC NEWS

May 16, 2026
pulisher
May 15, 2026

Kodiak Sciences stock hits 52-week highhere's why - MSN

May 15, 2026
pulisher
May 15, 2026

Kodiak Sciences (KOD) price target increased by 16.91% to 66.30 - MSN

May 15, 2026
pulisher
May 15, 2026

Sirenia Capital (KOD) and Alex Silverstein report 3,495,000 shares (5.7%) - Stock Titan

May 15, 2026
pulisher
May 14, 2026

Kodiak Sciences stock (US50012K1051): Q4 2025 earnings miss sparks investor focus - AD HOC NEWS

May 14, 2026
pulisher
May 14, 2026

Kodiak Sciences (KOD) up 2% since last earnings report: Can it continue? - MSN

May 14, 2026
pulisher
May 14, 2026

J.P. Morgan Maintains Kodiak Sciences(KOD.US) With Buy Rating, Cuts Target Price to $56 - Moomoo

May 14, 2026
pulisher
May 13, 2026

Number of shareholders of Kodiak Sciences Inc – NASDAQ:KOD - TradingView

May 13, 2026
pulisher
May 11, 2026

Chardan Capital upgrades Kodiak Sciences (KOD) - MSN

May 11, 2026
pulisher
May 11, 2026

TradingKey - TradingKey

May 11, 2026
pulisher
May 11, 2026

Kodiak Sciences stock is surging Friday: What's driving the action? - MSN

May 11, 2026
pulisher
May 11, 2026

KOD Upgraded by Chardan Capital -- Price Target Raised to $61.00 - GuruFocus

May 11, 2026
pulisher
May 11, 2026

This Pitney Bowes Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday - Benzinga

May 11, 2026
pulisher
May 11, 2026

Chardan upgrades Kodiak Sciences stock rating on drug trial results By Investing.com - Investing.com South Africa

May 11, 2026
pulisher
May 11, 2026

Chardan upgrades Kodiak Sciences stock rating on drug trial results - Investing.com

May 11, 2026
pulisher
May 11, 2026

H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $58 - Moomoo

May 11, 2026
pulisher
May 11, 2026

Kodiak's Q1 loss wider than expected, pipeline development in focus - MSN

May 11, 2026
pulisher
May 10, 2026

A Look At Kodiak Sciences (KOD) Valuation After Positive Phase 3 GLOW2 Results For Zenkuda - Yahoo Finance

May 10, 2026
pulisher
May 10, 2026

Zenkuda Phase 3 Win and Expanding Pipeline Might Change The Case For Investing In Kodiak Sciences (KOD) - Yahoo Finance

May 10, 2026
pulisher
May 10, 2026

Kodiak Sciences Zenkuda Data Shifts Focus To Retinal Pipeline Value - Sahm

May 10, 2026
pulisher
May 09, 2026

LifeSci Capital Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $65 - Moomoo

May 09, 2026
pulisher
May 08, 2026

Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus - The Globe and Mail

May 08, 2026
pulisher
May 08, 2026

KOD SEC FilingsKodiak Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 08, 2026
pulisher
May 08, 2026

LifeSci Capital Maintains Kodiak Sciences(KOD.US) With Buy Rating, Cuts Target Price to $65 - Moomoo

May 08, 2026
pulisher
May 08, 2026

Kodiak Sciences 1Q Loss/Shr 94c >KOD - Moomoo

May 08, 2026
pulisher
May 07, 2026

Kodiak Sciences : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Kodiak Sciences (NASDAQ: KOD) Q1 loss deepens as cash runway, going concern risk flagged - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Kodiak Sciences (NASDAQ: KOD) posts Q1 loss, highlights strong Phase 3 data - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Kodiak Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

KOD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

May 07, 2026
pulisher
May 07, 2026

Press Release: Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results - Moomoo

May 07, 2026
pulisher
May 06, 2026

Kodiak Sciences (KOD) Expected to Announce Earnings on Wednesday - MarketBeat

May 06, 2026
pulisher
May 04, 2026

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences - marketscreener.com

May 04, 2026
pulisher
May 03, 2026

Kodiak Sciences Inc. $KOD Stock Holdings Decreased by RIA Advisory Group LLC - MarketBeat

May 03, 2026
pulisher
May 01, 2026

Eye drug data from Taiwan cohort backs Kodiak Phase 3 expansion - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Kodiak Sciences Presents Pipeline Advances and KSI-101 Clinical Data At Scientific Conferences - marketscreener.com

May 01, 2026

Kodiak Sciences Inc (KOD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Kodiak Sciences Inc (KOD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BORGESON JOHN A.
Chief Financial Officer
Apr 02 '26
Option Exercise
1.04
30,000
31,200
213,316
BORGESON JOHN A.
Chief Financial Officer
Apr 02 '26
Sale
39.92
30,000
1,197,488
183,316
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
大文字化:     |  ボリューム (24 時間):